Oxford university spinout behind AstraZeneca Covid-19 jab pushes ahead with US listing
Home/FT/Vaccitech warns of blood clot risk in IPO filing FT Vaccitech warns of blood clot risk in IPO filing Financial Times0 Less than a minute Facebook X LinkedIn Oxford university spinout behind AstraZeneca Covid-19 jab pushes ahead with US listing Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
